TCW Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-11,914
Closed -$315K 771
2014
Q4
$315K Buy
11,914
+1,350
+13% +$39.5K ﹤0.01% 715
2014
Q3
$319K Hold
10,564
﹤0.01% 718
2014
Q2
$333K Hold
10,564
﹤0.01% 719
2014
Q1
$342K Sell
10,564
-11,000
-51% -$385K ﹤0.01% 735
2013
Q4
$784K Hold
21,564
﹤0.01% 713
2013
Q3
$839K Hold
21,564
﹤0.01% 709
2013
Q2
$808K Buy
+21,564
New +$851K ﹤0.01% 685

Other funds holding MR

TCW Group's MR Position: Q1 2015 in Review

TCW Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2015, closing a stake of 11,914 shares — an estimated $315K sold.

TCW Group first reported a position in MR in Q2 2013 and held it in 7 quarters. The position peaked at $839K in Q3 2013. 124 funds tracked by Wall St. Rank hold MR as of Q1 2015.

  • TCW Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2015 after selling out during the quarter.
  • TCW Group sold 11,914 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2015, an estimated $315K.
  • TCW Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 7 quarters.
  • TCW Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $839K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2015.

Based on TCW Group's 13F filing for Q1 2015, filed 13 May 2015.